Impact of heart failure and left ventricular function on long-term survival - Report of a community-based cohort study in Taiwan

被引:28
|
作者
Huang, Chien-Hua
Chien, Kuo-Liong
Chen, Wen-Jone
Sung, Fung-Chang
Hsu, Hsiu-Ching
Su, Ta-Chen
Lee, Yuan-Teh
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med Cardiol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med Cardiol, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Emergency Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Sch Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan
[5] China Med Univ, Inst Environm Med, Taichung, Taiwan
[6] Minsheng Gen Hosp, Dept Internal Med Cardiol, Tao Yuan, Taiwan
关键词
heart failure; systolic function; all-cause mortality; community-based; Chinese;
D O I
10.1016/j.ejheart.2007.02.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is little community-based information on heart failure (HF) prognosis in ethnic Chinese populations, in whom there is a low prevalence of coronary heart disease. Aims: To study the impact of HF and left ventricular function on long-term all-cause mortality. Methods and results: This community-based prospective cohort study included 2660 subjects (1215 men, 1445 women, mean age 54.4 +/- 11.9 years) over a 10 year follow-up period. The prevalence of HF was 5.5%. Hypertension was the most common factor related to HE The five and ten year all-cause mortality was higher in the HF/preserved LVEF group (14.1% and 24.4%) and the HF/impaired LVEF group (29.2% and 48.2%) than in the HF-free group (6.0% and 14.6%, p<0.0001 for both). In multivariable Cox analyses, controlling for sex, LV mass, atrial fibrillation, hypertension, coronary heart disease, HF/preserved LVEF and HF/impaired LVEF were important predictors of all-cause mortality (p=0.007). Conclusions: Hypertension is a major heart failure related disease. HF and LV systolic dysfunction are associated with a significant increase in all-cause mortality in an ethnic Chinese population. (C) 2007 European Society of Cardiology. Published by Elsevier B.V All tights reserved.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 50 条
  • [41] Differences in short and long-term survival between males and females with new-onset heart failure: A retrospective cohort study
    Chodick, Gabriel
    Weitzman, Dahlia
    Blaustein, Robert O.
    Shalev, Varda
    Bash, Lori D.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 41 : E21 - E23
  • [42] The impact of statin use on short-term and long-term mortality in patients with heart failure
    Zheng, Xiaoxue
    Tan, Long
    Zhang, Yu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Reninangiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan
    Tang, Chao-Hsiun
    Chen, Tso-Hsiao
    Wang, Chia-Chen
    Hong, Chuang-Ye
    Huang, Kuan-Chih
    Sue, Yuh-Mou
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1194 - 1202
  • [44] Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure
    Sassara, M
    Achilli, A
    Bianchi, S
    Ficili, S
    Marullo, A
    Pontillo, D
    Achilli, P
    Peraldo, C
    Sgreccia, F
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (06): : 805 - 807
  • [45] Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure
    George Suzuki
    Sanjaya Khanal
    Sharad Rastogi
    Hideaki Morita
    Takayuki Mishima
    Petros V. Anagnostopoulos
    Omar Nass
    Victor G. Sharov
    Elaine J. Tanhehco
    Sidney Goldstein
    Hani N. Sabbah
    Cardiovascular Drugs and Therapy, 2007, 21 : 29 - 36
  • [46] Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure
    Mulder, P
    Barbier, S
    Chagraoui, A
    Richard, V
    Henry, JP
    Lallemand, F
    Renet, S
    Lerebours, G
    Mahlberg-Gaudin, F
    Thuillez, C
    CIRCULATION, 2004, 109 (13) : 1674 - 1679
  • [47] Long-term pharmacological activation of PPARγ does not prevent left ventricular remodeling in dogs with advanced heart failure
    Suzuki, George
    Khanal, Sanjaya
    Rastogi, Sharad
    Morita, Hideaki
    Mishima, Takayuki
    Anagnostopoulos, Petros V.
    Nass, Omar
    Sharov, Victor G.
    Tanhehco, Elaine J.
    Goldstein, Sidney
    Sabbah, Hani N.
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (01) : 29 - 36
  • [48] Long-term Carperitide Treatment Attenuates Left Ventricular Remodeling in Rats With Heart Failure After Autoimmune Myocarditis
    Tanaka, Komei
    Ito, Masahiro
    Kodama, Makoto
    Hoyano, Makoto
    Kimura, Shinpei
    Mitsuma, Wataru
    Hirono, Satoru
    Adachi, Takeshi
    Watanabe, Kenichi
    Nakazawa, Mikio
    Aizawa, Yoshifusa
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 54 (03) : 232 - 239
  • [49] Multiparametric approach to congestion for predicting long-term survival in heart failure
    Massari, Francesco
    Scicchitano, Pietro
    Iacoviello, Massimo
    Passantino, Andrea
    Guida, Piero
    Sanasi, Mariella
    Piscopo, Assunta
    Romito, Roberta
    Valle, Roberto
    Caldarola, Pasquale
    Ciccone, Marco Matteo
    JOURNAL OF CARDIOLOGY, 2020, 75 (01) : 47 - 52
  • [50] Anemia and Heart Failure in a Community-based Cohort: Comparison with a Specialized Outpatient Clinic
    dos Santos, Eduarda Barcellos
    Tello, Bolivar Saenz
    Villacorta, Humberto
    Ferreira Sales, Ana Luisa
    Wiefels, Christiane
    Teixeira, Pedro Soares
    Lima Filho, Luis Costa
    Mesquita, Evandro Tinoco
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (01) : 102 - 108